Puxeddu E - Search Results

1

The natural history of benign thyroid nodules.

Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, Puxeddu E, Torlontano M, Tumino S, Attard M, Lamartina L, Nicolucci A, Filetti S. Durante C, et al. Among authors: puxeddu e. JAMA. 2015 Mar 3;313(9):926-35. doi: 10.1001/jama.2015.0956. JAMA. 2015. PMID: 25734734

2

Radioiodine uptake in non-lactating mammary glands: evidence for a causative role of hyperprolactinemia.

Ronga G, Bruno R, Puxeddu E, Calcinaro F, Montesano T, Travascio L, Colandrea M, Durante C, Maranghi M, Filetti S, Russo D. Ronga G, et al. Among authors: puxeddu e. Thyroid. 2007 Apr;17(4):363-6. doi: 10.1089/thy.2006.0282. Thyroid. 2007. PMID: 17465868

3

BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism.

Durante C, Puxeddu E, Ferretti E, Morisi R, Moretti S, Bruno R, Barbi F, Avenia N, Scipioni A, Verrienti A, Tosi E, Cavaliere A, Gulino A, Filetti S, Russo D. Durante C, et al. Among authors: puxeddu e. J Clin Endocrinol Metab. 2007 Jul;92(7):2840-3. doi: 10.1210/jc.2006-2707. Epub 2007 May 8. J Clin Endocrinol Metab. 2007. PMID: 17488796

4

Clinical implications of BRAF mutation in thyroid carcinoma.

Puxeddu E, Durante C, Avenia N, Filetti S, Russo D. Puxeddu E, et al. Trends Endocrinol Metab. 2008 May-Jun;19(4):138-45. doi: 10.1016/j.tem.2007.12.003. Epub 2008 Mar 11. Trends Endocrinol Metab. 2008. PMID: 18337114 Review.

5

High periostin expression correlates with aggressiveness in papillary thyroid carcinomas.

Puppin C, Fabbro D, Dima M, Di Loreto C, Puxeddu E, Filetti S, Russo D, Damante G. Puppin C, et al. Among authors: puxeddu e. J Endocrinol. 2008 May;197(2):401-8. doi: 10.1677/JOE-07-0618. J Endocrinol. 2008. PMID: 18434370

6

Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAF(V600E) mutation.

Franzoni A, Dima M, D'Agostino M, Puppin C, Fabbro D, Loreto CD, Pandolfi M, Puxeddu E, Moretti S, Celano M, Bruno R, Filetti S, Russo D, Damante G. Franzoni A, et al. Among authors: puxeddu e. Thyroid. 2009 Mar;19(3):247-55. doi: 10.1089/thy.2008.0235. Thyroid. 2009. PMID: 19207009

7

A useful ultrasound score to select thyroid nodules requiring fine needle aspiration in an iodine-deficient area.

Cavaliere A, Colella R, Puxeddu E, Gambelunghe G, Falorni A, Stracci F, d'Ajello M, Avenia N, De Feo P. Cavaliere A, et al. Among authors: puxeddu e. J Endocrinol Invest. 2009 May;32(5):440-4. doi: 10.1007/BF03346483. Epub 2009 Apr 15. J Endocrinol Invest. 2009. PMID: 19494709

8

The 2009 American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: progress on the road from consensus- to evidence-based practice.

Puxeddu E, Filetti S. Puxeddu E, et al. Thyroid. 2009 Nov;19(11):1145-7. doi: 10.1089/thy.2009.1601. Thyroid. 2009. PMID: 19888856 No abstract available.

9

Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.

Paolino D, Cosco D, Racanicchi L, Trapasso E, Celia C, Iannone M, Puxeddu E, Costante G, Filetti S, Russo D, Fresta M. Paolino D, et al. Among authors: puxeddu e. J Control Release. 2010 Jun 1;144(2):144-50. doi: 10.1016/j.jconrel.2010.02.021. Epub 2010 Feb 22. J Control Release. 2010. PMID: 20184929

10

Nucleophosmin is overexpressed in thyroid tumors.

Pianta A, Puppin C, Franzoni A, Fabbro D, Di Loreto C, Bulotta S, Deganuto M, Paron I, Tell G, Puxeddu E, Filetti S, Russo D, Damante G. Pianta A, et al. Among authors: puxeddu e. Biochem Biophys Res Commun. 2010 Jul 2;397(3):499-504. doi: 10.1016/j.bbrc.2010.05.142. Epub 2010 May 31. Biochem Biophys Res Commun. 2010. PMID: 20515654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page